Los Angeles, California. January 26, 2017 Lecture Topic: Prostate Cancer Markers Category: Prostate Cancer Markers
Los Angeles, California. January 26, 2017 Lecture Topic: Prostate Cancer Markers Category: Prostate Cancer Markers
Loeb S. Editorial Comment on “Variation in Guideline Concordant Active Surveillance Followup in Diverse Urology Practices.” Journal of Urology 2016 epub Nov 28. PMID: 27908693. Link: https://www.ncbi.nlm.nih.gov/pubmed/27908693
Tosoian JJ, Loeb S, Epstein JI, Turkbey B, Choyke PL, Schaeffer EM. “Active Surveillance of Prostate Cancer: Use, Outcomes, Imaging, and Diagnostic Tools.” American Society of Clinical Oncology Educational Book. 2016;35:e235-45. PMID: 27249729 Link: https://pubmed.ncbi.nlm.nih.gov/27249729/
Adam M, Tennstedt P, Lanwehr D, Tilki D, Steuber T, Beyer B, Thederan I, Heinzer H, Haese A, Salomon G, Budäus L, Michl U, Pehrke D, Stattin P, Bernard J, Klaus B, Pompe RS, Petersen C, Huland H, Graefen M, Schwarz R, Huber W, Loeb S, Schlomm T. “Functional Outcomes and Quality of Life After… Read More
Lundström KJ, Folkvaljon Y, Loeb S, Axelson AB, Stattin P, Nordin P. “Small bowel obstruction and abdominal pain after robotic versus open radical prostatectomy.” Scandinavian Journal of Urology. 2016 Mar 3:1-5 epub. PMID: 26936203. Link: http://www.ncbi.nlm.nih.gov/pubmed/26936203
Loeb S, Folkvaljon Y, Robinson D, Schlomm T, Garmo H, Stattin P. “Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer Treatment.” European Urology. 2015 Dec 29 epub. PMID: 26743040 Link: http://www.ncbi.nlm.nih.gov/pubmed/26743040
Sidney, Australia. September 2016 Lecture Topics: Prostate Cancer Markers Category: Prostate Cancer, Markers
Panama. October 2016 Lecture Topics: Prostate Cancer Active Surveillance, SelectMDx and ConfirmMDx Prostate Cancer Markers, Social Media in Urology Categories: Prostate Cancer, Social Media
Interview on Katz’s Corner on 77 WABC Radio about Erectile Dysfunction Medications and Risk of Melanoma (June 28, 2015) https://audioboom.com/boos/3323526-6-28-15-dr-stacy-loeb-prostate-cancer-supplements
Onc Live Interview on Considerations for Screening in Prostate Cancer (June 2016)
Carlsbad, California. October 26-29, 2016 Lecture topic: Social media in prostate cancer Category: Social Media
London, England. Ocrober 21, 2016 Lecture topic: Active Surveillance- USA Perspective Category: Prostate Cancer
Napa, California. August 2016 Lecture Topics: Who to Biopsy and Rebiopsy, Tissue-Based Markers for Prostate Cancer Risk Stratification, Biomarker Panel Category: Prostate Cancer, Biopsy, Markers
Nickel JC, Gorin MA, Partin AW, Assimos D, Brawer M, Nicolai H, Chancellor MB, Goggins Á, Loeb S, Shapiro E. “Best of the 2009 AUA Annual Meeting: Highlights from the 2009 Annual Meeting of the American Urological Association, April 25-30, 2009, Chicago, IL.” Reviews in Urology 2015;17(3):179-89. PMID: 26543434 Link: http://www.ncbi.nlm.nih.gov/pubmed/26543434
Tosoian JJ, Carter HB, Lepor A, Loeb S. “Active surveillance for prostate cancer: current evidence and contemporary state of practice.” Nature Reviews Urology 2016 Mar 8 epub. PMID: 26954332. Link: http://www.ncbi.nlm.nih.gov/pubmed/26954332/
Loeb S. “Re: Long-Term Follow-up of a Large Active Surveillance Cohort of Patients with Prostate Cancer.” European Urology 2015 Nov; 68: 907. PMID: 26460874. Link: http://www.ncbi.nlm.nih.gov/pubmed/26460874
Loeb S, Folkvaljon Y, Robinson D, Makarov DV, Bratt O, Garmo H, and Stattin P. “Immediate versus delayed prostatectomy: Nationwide population-based study.” Scandinavian Journal of Urology 2016 Apr 12 epub. PMID: 27067998. Link: http://www.ncbi.nlm.nih.gov/pubmed/27067998
Key Papers Yang H, Breyer BN, Rimm EB, Giovannucci E, Loeb S, Kenfield SA, Bauer SR. “Plant-based diet index and erectile dysfunction in the Health Professionals Follow-Up Study.” British Journal of Urology International. epub 2022 Apr 28. PMID: 35484829. Link: https://pubmed.ncbi.nlm.nih.gov/35484829/ A healthy plant-based diet is associated with a lower risk of erectile dysfunction… Read More
Loeb S, Folkvaljon Y, Robinson D, Lissbrant IF, Egevad L, Stattin P. “Evaluation of the 2015 Gleason Grade Groups in a Nationwide Population-based Cohort.” European Urology. 2015 Dec 17 epub. PMID: 26707871 Link: http://www.ncbi.nlm.nih.gov/pubmed/26707871
Loeb S, Curnyn C, Sedlander E. “Perspectives of Prostate Cancer Patients on Gleason Scores and the New Grade Groups: Initial Qualitative Study.” European Urology 2016 Jun 6 epub. PMID: 27283215. Link: http://www.ncbi.nlm.nih.gov/pubmed/27283215 This is the first qualitative study to ask patients their perspectives on Gleason grading, which is a significant source of confusion. The majority… Read More
Loeb S. “Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening.” Journal of Clinical Oncology 2016 Jun 20 epub. PMID: 27325846. Link: http://www.ncbi.nlm.nih.gov/pubmed/27325846
Loeb S, Lilja H, Vickers A. “Beyond prostate-specific antigen: utilizing novel strategies to screen men for prostate cancer.” Current Opinion in Urology 2016 Jun 3 epub. PMID: 27262138 Link: http://www.ncbi.nlm.nih.gov/pubmed/27262138
Loeb S. “Will Changes to Prostate Cancer Screening Guidelines Preserve Benefits and Reduce Harms?” European Urology 2016 April epub. PMID: 27090973. Link: http://www.ncbi.nlm.nih.gov/pubmed/27090973
Munich, Germany. March 11-14, 2016 Lecture Topics: Prostate Cancer Markers Category: Prostate Cancer
Acapulco, Mexico. July 20-22, 2016 Lecture topics:Social media, Prostate Cancer Markers, Prostate Biopsy Complications, Active Surveillance Category: Prostate Cancer, Social Media
Israel. July 7-8, 2016 Lecture Topics: Active Surveillance, Prostate Cancer Treatment Category: Prostate Cancer
Ireland. April 21-22, 2016 Lecture Topics: Smarter Prostate Cancer Screening; Prostate Cancer Treatment Category: Prostate Cancer
Sotelo R, Mora K. E, Perez L. H, Novoa J, Castillo M, Carmona O, De Andrade R, Loeb S, and Catalona WJ. “Assay Standardization Bias: Different Prostate Cancer Detection Rates and Clinical Outcomes Resulting From Different Assays for Free and Total Prostate-Specific Antigen (PSA).” Urology, June 2007; 69: 1143. Link: http://www.ncbi.nlm.nih.gov/pubmed/17572203
Loeb S. “Guideline of guidelines: prostate cancer screening.” BJU International 2014 September; 114: 323. PMID: 24981126. Link: http://www.ncbi.nlm.nih.gov/pubmed/23567643
Loeb S, Vonesh EF, Metter EJ, Carter HB, Gann PH, and Catalona WJ. “What is the true number-needed-to-screen and treat to save a life with prostate-specific antigen (PSA) testing?” Journal of Clinical Oncology January 2011; 29: 464. Link: http://www.ncbi.nlm.nih.gov/pubmed/21189374 Although number needed to screen (NNS) and number needed to treat (NNT) are useful statistics to… Read More
Schaeffer EM, Carter HB, Kettermann A, Loeb S, Ferrucci L, Landis P, Trock BJ, and Metter EJ. “Prostate Specific Antigen Testing Among the Elderly: When to Stop?” Journal of Urology, April 2009; 181: 1606. Link: http://www.ncbi.nlm.nih.gov/pubmed/19246059 Men ages 75-80 with PSA levels <3 ng/ml are unlikely to die of or experience aggressive prostate cancer… Read More
Loeb S, Carter HB, Catalona WJ, Moul JW, and Schroder FH. “Baseline Prostate-Specific Antigen Testing at a Young Age.” European Urology January 2012; 61: 1-7. PMID: 21862205. Link: http://www.ncbi.nlm.nih.gov/pubmed/21862205 This study reviews the published literature showing that baseline PSA measurements at a young age are significant predictors of later prostate cancer diagnosis and disease-specific outcomes…. Read More
Loeb S, Roehl KA, Antenor JV, Catalona WJ, Suarez BK, and Nadler RB. “Baseline Prostate Specific Antigen (PSA) Compared with Median PSA for Age Group as Predictor of Prostate Cancer Risk in Men Under 60 Years of Age” Urology, February 2006; 67: 316. Link: http://www.ncbi.nlm.nih.gov/pubmed/16442597 In the general US population, the median PSA level is… Read More
Murphy DG, Ahlering T, Catalona WJ, Crowe H, Crowe J, Clarke N, Cooperberg M, Gillatt D, Gleave M, Loeb S, Roobol M, Sartor O, Pickles T, Wooten A, Walsh PC, Costello AJ. “The Melbourne Consensus Statement on the Early Detection of Prostate Cancer.” British Journal of Urology International 2012 epub Nov 8. PMID: 24206066 Link:… Read More
Loeb S, Byrne N, Walter D, Makarov DV, Wise DR, Becker D, Giri VN. “Knowledge and practice regarding prostate cancer germline testing among urologists: Gaps to address for optimal implementation.” Cancer Treat Res Commun. 2020 Sep 28;25:100212. PMID: 33091732 Link: https://pubmed.ncbi.nlm.nih.gov/33091732/
Lynch HT, Kosoko-Lasaki O, Leslie SW, Rendell M, Shaw T, Snyder C, D’Amico AV, Buxbaum S, Isaacs WB, Loeb S, Moul JW, Powell I. “Screening for Familial and Hereditary Prostate Cancer“. International Journal of Cancer. 2015 Dec 5 epub. PMID: 26638190 Link: http://www.ncbi.nlm.nih.gov/pubmed/26638190
Loeb S, Helfand BT, Kan D, Isaacs WB, and Catalona WJ. “Does Diabetes Mellitus Modify the Association between 17q12 Risk Variant and Prostate Cancer Aggressiveness?” BJU International, November 2009; 104: 1200. Link: http://www.ncbi.nlm.nih.gov/pubmed/19627283
Helfand BT, Loeb S, Kan D, Catalona WJ. “Number of prostate cancer risk alleles may identify possibly ‘insignificant’ disease.” BJU International, June 2010 epub. Link: http://www.ncbi.nlm.nih.gov/pubmed/20590552
Helfand BT, Fought AJ, Loeb S, Meeks JJ, Kan D, and Catalona WJ. “Genetic prostate cancer risk assessment: common variants in 9 genomic regions are associated with cumulative risk.” Journal of Urology, August 2010; 184: 501. Link: http://www.ncbi.nlm.nih.gov/pubmed/20620408
Cooper PR, McGuire BB, Helfand BT, Loeb S, Hu Q, and Catalona WJ. “Prostate Cancer Risk Alleles and Their Associations with Other Malignancies.” Urology October 2011; 78: 970 .e 15-20. PMID: 21820706. Link: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3190015/